Skip to main navigation Skip to search Skip to main content

FcRn as a Determinant of IgG Bioavailability

Project: Research

Project Details

StatusFinished
Effective start/end date02/15/07 → 09/30/07

Funding

  • Novartis Pharma AG: $98,345.07